Modern view on the role of microbiota in chemotherapy in children
Russian Journal of Oncology · 04.03.2026 · 31 (1) · 42-53
DOI: 10.17816/onco696672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Journal of Oncology, online erschienen am 04.03.2026. Verfasst von Almaz Ch. Islamgulov und 6 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben.
Themen: Onkologische Pflege, Kinderkrankenpflege
Abstract (Originalsprache)
The gut microbiota (GM) plays an important role in modulating the effectiveness and toxicity of chemotherapy (CT) in children with oncological diseases. In this review, the authors analyzed and systematized current data on the role of GM in the tolerability and effectiveness of therapy in acute leukemias and demonstrated the interrelation between CT and GM. Chemotherapy causes changes in GM: it reduces the number of different bacterial species, decreases the number of beneficial species, and increases the abundance of opportunistic bacteria, which increases the risk of complications such as mucositis, febrile neutropenia, and sepsis. The reciprocal effect of GM on CT occurs through direct impact on the metabolism of cytostatics and systemic immunomodulation. One of the important mechanisms of GM influence is the formation of short-chain fatty acids, particularly butyrate, which enhances the function of cytotoxic T-lymphocytes, induces apoptosis of tumor cells, and supports normal intestinal function. Promising directions for dysbiosis correction are probiotics, prebiotics, and fecal microbiota transplantation, which shows high effectiveness in steroid-resistant graft-versus-host disease. Integration of microbiome biomarker research into prognostic models and the use of multi-omics technologies provide an opportunity for the development of individualized treatment approaches. Based on the available data, GM is an important factor in the effective delivery of CT in children, and methods of its modification have high potential for improving survival and quality of life in these patients, which requires further confirmation in randomized controlled trials.
Zitieren
APA
Islamgulov, A. C., Murtazin, A. A., Malievsky, V. A., Kalmetyeva, L. R., Proligina, D. D., Davletbaeva, G. A., & Gazizullina, G. R. (2026). Modern view on the role of microbiota in chemotherapy in children. Russian Journal of Oncology, 31(1), 42-53. https://doi.org/10.17816/onco696672
Vancouver
Islamgulov AC, Murtazin AA, Malievsky VA, Kalmetyeva LR, Proligina DD, Davletbaeva GA, et al. Modern view on the role of microbiota in chemotherapy in children. Russian Journal of Oncology. 2026;31(1):42-53. doi:10.17816/onco696672
BibTeX
@article{Islamgulov2026,
author = {Islamgulov, Almaz Ch. and Murtazin, Azat A. and Malievsky, Viktor A. and Kalmetyeva, Linara R. and Proligina, Dilyara D. and Davletbaeva, Gulchat A. and Gazizullina, Gulnara R.},
title = {Modern view on the role of microbiota in chemotherapy in children},
journal = {Russian Journal of Oncology},
year = {2026},
volume = {31},
number = {1},
pages = {42--53},
doi = {10.17816/onco696672}
}
EUVIMED